BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin QY, Zhang YL, Bai J, Liu JQ, Li HH. VEGF-C/VEGFR-3 axis protects against pressure-overload induced cardiac dysfunction through regulation of lymphangiogenesis. Clin Transl Med 2021;11:e374. [PMID: 33783987 DOI: 10.1002/ctm2.374] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Meng W, Zhang H, Zhu J, Wang Q, Mou F, Guo H. Lymphangiogenesis, a potential treatment target for myocardial injury. Microvascular Research 2023;145:104442. [DOI: 10.1016/j.mvr.2022.104442] [Reference Citation Analysis]
2 Wu Z, Yu X, Zhang S, He Y, Guo W. Mechanism underlying circRNA dysregulation in the TME of digestive system cancer. Front Immunol 2022;13:951561. [DOI: 10.3389/fimmu.2022.951561] [Reference Citation Analysis]
3 Zhang L, Ye C, Li P, Li C, Shu W, Zhao Y, Wang X. ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-κB pathway by the secretome. Stem Cell Res Ther 2022;13:448. [PMID: 36064450 DOI: 10.1186/s13287-022-03132-3] [Reference Citation Analysis]
4 Cornuault L, Rouault P, Duplàa C, Couffinhal T, Renault M. Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs? Front Physiol 2022;13:906272. [DOI: 10.3389/fphys.2022.906272] [Reference Citation Analysis]
5 Heron C, Dumesnil A, Houssari M, Renet S, Lemarcis T, Lebon A, Godefroy D, Schapman D, Henri O, Riou G, Nicol L, Henry JP, Valet M, Pieronne-Deperrois M, Ouvrard-Pascaud A, Hägerling R, Chiavelli H, Michel JB, Mulder P, Fraineau S, Richard V, Tardif V, Brakenhielm E. Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure. Cardiovasc Res 2022:cvac086. [PMID: 35689481 DOI: 10.1093/cvr/cvac086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Huston JH, Shah SJ. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease. Circ Res 2022;130:1382-403. [PMID: 35482841 DOI: 10.1161/CIRCRESAHA.122.319967] [Reference Citation Analysis]
7 Dozic S, Janssens JV, Weeks KL. Lymphangiogenesis: A new player in the heart's adaptive response to exercise. Journal of Sport and Health Science 2022. [DOI: 10.1016/j.jshs.2022.03.007] [Reference Citation Analysis]
8 Han X, Zhang YL, Lin QY, Li HH, Guo SB. ATGL deficiency aggravates pressure overload-triggered myocardial hypertrophic remodeling associated with the proteasome-PTEN-mTOR-autophagy pathway. Cell Biol Toxicol 2022. [PMID: 35218467 DOI: 10.1007/s10565-022-09699-0] [Reference Citation Analysis]
9 Bei Y, Huang Z, Feng X, Li L, Wei M, Zhu Y, Liu S, Chen C, Yin M, Jiang H, Xiao J. Lymphangiogenesis contributes to exercise-induced physiological cardiac growth: Running title: Lymphangiogenesis in physiological hypertrophy. J Sport Health Sci 2022:S2095-2546(22)00037-0. [PMID: 35218948 DOI: 10.1016/j.jshs.2022.02.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Bai J, Yin L, Yu W, Zhang Y, Lin Q, Li H, Brody M. Angiotensin II Induces Cardiac Edema and Hypertrophic Remodeling through Lymphatic-Dependent Mechanisms. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/5044046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Zhou Y, Zhu X, Cui H, Shi J, Yuan G, Shi S, Hu Y. The Role of the VEGF Family in Coronary Heart Disease. Front Cardiovasc Med 2021;8:738325. [PMID: 34504884 DOI: 10.3389/fcvm.2021.738325] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
12 Stritt S, Koltowska K, Mäkinen T. Homeostatic maintenance of the lymphatic vasculature. Trends Mol Med 2021:S1471-4914(21)00184-2. [PMID: 34332911 DOI: 10.1016/j.molmed.2021.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
13 Zhang C, Li N, Suo M, Zhang C, Liu J, Liu L, Qi Y, Zheng X, Xie L, Hu Y, Bu P. Sirtuin 3 deficiency aggravates angiotensin II-induced hypertensive cardiac injury by the impairment of lymphangiogenesis. J Cell Mol Med 2021;25:7760-71. [PMID: 34180125 DOI: 10.1111/jcmm.16661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Heron C, Dumesnil A, Houssari M, Renet S, Lebon A, Godefroy D, Schapman D, Henri O, Riou G, Nicol L, Henry J, Pieronne-deperrois M, Ouvrard-pascaud A, Hägerling R, Chiavelli H, Michel J, Mulder P, Fraineau S, Richard V, Tardif V, Brakenhielm E. Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure.. [DOI: 10.1101/2021.04.27.441616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]